| Literature DB >> 30465714 |
Natalie Reimers1, Klaus Pantel2.
Abstract
"Liquid biopsy" was introduced as a new diagnostic concept in 2010 for the analysis of circulating tumor cells (CTCs) and has been now extended to material (in particular DNA) released by tumor cells in the peripheral blood of cancer patients. Over the past decade, various methods have been developed to detect CTCs and ctDNA in the peripheral blood of cancer patients.Entities:
Keywords: circulating tumor cells; liquid biopsy; minimal residual disease
Mesh:
Substances:
Year: 2019 PMID: 30465714 DOI: 10.1515/cclm-2018-0610
Source DB: PubMed Journal: Clin Chem Lab Med ISSN: 1434-6621 Impact factor: 3.694